Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 1 (2004), Issue 1 (November)

1. Regional differences in the manifestation of gastrointestinal motor disorders in type 1 diabetic patients with autonomic neuropathy.
   Z Gastroenterol, 42(11): 1295-300. [Abstract] [Full-text]
2. Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats.
   Braz J Med Biol Res, 37(12): 1895-902. [Abstract] [Full-text]
3. Trends in cardiovascular complications of diabetes.
   JAMA, 292(20): 2495-9. [Abstract] [Full-text]
4. Routine use of bilateral skeletonized internal thoracic artery grafts in middle-aged diabetic patients.
   Ann Thorac Surg, 78(6): 2050-3. [Abstract] [Full-text]
5. Gender differences in healthcare utilization and medical indicators among patients with diabetes.
   Public Health, 119(1): 45-9. [Abstract] [Full-text]
6. The macrophage-activating lipopeptide-2 accelerates wound healing in diabetic mice.
   Exp Dermatol, 13(12): 731-9. [Abstract] [Full-text]
7. The role of serum insulin-like growth factor I (IGF-I) in neonatal outcome.
   J Clin Pathol, 57(12): 1299-301. [Abstract] [Full-text]
8. Advice that includes food sources of unsaturated fat supports future risk management of gestational diabetes mellitus.
   J Am Diet Assoc, 104(12): 1863-7. [Abstract] [Full-text]
9. Postprandial glucose response to Chinese foods in patients with type 2 diabetes.
   J Am Diet Assoc, 104(12): 1854-8. [Abstract] [Full-text]
10. Research navigating the course of clinical practice in diabetes.
    J Am Diet Assoc, 104(12): 1846-53. [Abstract] [Full-text]
11. Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
    J Am Diet Assoc, 104(12): 1816-26. [Abstract] [Full-text]
12. Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes.
    J Am Diet Assoc, 104(12): 1805-15. [Abstract] [Full-text]
13. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.
    Ophthalmologica, 218(6): 378-84. [Abstract] [Full-text]
14. Common genetic basis between type 1 and type 2 diabetes mellitus indicated by interview-based assessment of family history.
    Diabetes Res Clin Pract, 66: S91-5. [Abstract] [Full-text]
15. Idd1 and Idd3 are necessary but not sufficient for development of type 1 diabetes in NOD mouse.
    Diabetes Res Clin Pract, 66: S85-90. [Abstract] [Full-text]
16. Prevention and treatment of macroangiopathy: focusing on oxidative stress.
    Diabetes Res Clin Pract, 66: S57-62. [Abstract] [Full-text]
17. Can diabetic neuropathy be prevented?
    Diabetes Res Clin Pract, 66: S53-6. [Abstract] [Full-text]
18. Pericytes and the prevention of diabetic retinopathy.
    Diabetes Res Clin Pract, 66: S49-51. [Abstract] [Full-text]
19. Genome-wide search for susceptibility gene to diabetic nephropathy by gene-based SNP.
    Diabetes Res Clin Pract, 66: S45-7. [Abstract] [Full-text]
20. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes.
    Diabetes Res Clin Pract, 66: S37-43. [Abstract] [Full-text]
21. Prevention of type 2 diabetes mellitus from the viewpoint of genetics.
    Diabetes Res Clin Pract, 66: S33-5. [Abstract] [Full-text]
22. Recent advance in hepatic insulin gene therapy.
    Diabetes Res Clin Pract, 66: S3-S10. [Abstract] [Full-text]
23. Prevention of type 1 diabetes: from the view point of beta cell damage.
    Diabetes Res Clin Pract, 66: S27-32. [Abstract] [Full-text]
24. Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes.
    Diabetes Res Clin Pract, 66: S19-25. [Abstract] [Full-text]
25. Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes.
    Diabetes Res Clin Pract, 66: S173-7. [Abstract] [Full-text]
26. An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea.
    Diabetes Res Clin Pract, 66: S169-72. [Abstract] [Full-text]
27. History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy.
    Diabetes Res Clin Pract, 66: S165-8. [Abstract] [Full-text]
28. Significantly higher incidence of carotid atherosclerosis found in Japanese type 2 diabetic patients with early nephropathy.
    Diabetes Res Clin Pract, 66: S161-3. [Abstract] [Full-text]
29. Rice bran extract prevents the elevation of plasma peroxylipid in KKAy diabetic mice.
    Diabetes Res Clin Pract, 66: S157-60. [Abstract] [Full-text]
30. Anti-hyperglycemic activity of Commelina communis L.: inhibition of alpha-glucosidase.
    Diabetes Res Clin Pract, 66: S149-55. [Abstract] [Full-text]
31. Meta-analysis of three diabetes population studies: association of inactive ALDH2 genotype with maternal inheritance of diabetes.
    Diabetes Res Clin Pract, 66: S145-7. [Abstract] [Full-text]
32. Development of web-based diabetic patient management system using short message service (SMS).
    Diabetes Res Clin Pract, 66: S133-7. [Abstract] [Full-text]
33. Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide.
    Diabetes Res Clin Pract, 66: S129-32. [Abstract] [Full-text]
34. A case of type 2 diabetes with high levels of plasma and urinary C-peptide.
    Diabetes Res Clin Pract, 66: S125-8. [Abstract] [Full-text]
35. Possible contribution of adipocytokines on diabetic neuropathy.
    Diabetes Res Clin Pract, 66: S121-3. [Abstract] [Full-text]
36. Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.
    Diabetes Res Clin Pract, 66: S115-20. [Abstract] [Full-text]
37. Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus.
    Diabetes Res Clin Pract, 66: S11-7. [Abstract] [Full-text]
38. Evalution of oxidative stress in diabetic animals by in vivo electron spin resonance measurement--role of protein kinase C.
    Diabetes Res Clin Pract, 66: S109-13. [Abstract] [Full-text]
39. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus.
    Clin Chim Acta, 351(1): 197-201. [Abstract] [Full-text]
40. Effect of N-benzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats.
    Clin Chim Acta, 351(1): 105-13. [Abstract] [Full-text]
41. Effect of alpha-tocopherol supplementation on blood pressure and lipidic profile in streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats.
    Clin Chim Acta, 351(1): 101-4. [Abstract] [Full-text]
42. Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review.
    J Pharm Pharmacol, 56(12): 1477-92. [Abstract] [Full-text]
43. Derivative weighted active insulin control modelling and clinical trials for ICU patients.
    Med Eng Phys, 26(10): 855-66. [Abstract] [Full-text]
44. Patients with type 2 diabetes had higher rates of hospitalization than the general population.
    J Clin Epidemiol, 57(11): 1196-201. [Abstract] [Full-text]
45. Depression and diabetes symptom burden.
    Gen Hosp Psychiatry, 26(6): 430-6. [Abstract] [Full-text]
46. alpha-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats.
    Biochem Biophys Res Commun, 326(1): 197-202. [Abstract] [Full-text]
47. Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction.
    Am J Cardiol, 94(11): 1391-5. [Abstract] [Full-text]
48. The obesity epidemic: prospects for prevention.
    QJM, 97(12): 817-25. [Abstract] [Full-text]
49. Recent advances in the monitoring and management of diabetic ketoacidosis.
    QJM, 97(12): 773-80. [Abstract] [Full-text]
50. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen.
    Kidney Int, 66(6): 2337-47. [Abstract] [Full-text]
51. Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis.
    Kidney Int, 66(6): 2308-14. [Abstract] [Full-text]
52. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
    Basic Clin Pharmacol Toxicol, 95(6): 252-62. [Abstract] [Full-text]
53. Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
    Diabet Med, 21(12): 1368-71. [Abstract] [Full-text]
54. Reversible cognitive deterioration after a single episode of severe hypoglycaemia: a case report.
    Diabet Med, 21(12): 1366-7. [Abstract] [Full-text]
55. Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS).
    Diabet Med, 21(12): 1357-65. [Abstract] [Full-text]
56. Prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study: methodology.
    Diabet Med, 21(12): 1353-6. [Abstract] [Full-text]
57. Erythromelia, or Mitchell's syndrome--new names for unexplained signs of inflammation in distal symmetrical neuropathy in diabetes.
    Diabet Med, 21(12): 1334-8. [Abstract] [Full-text]
58. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes.
    Diabet Med, 21(12): 1325-33. [Abstract] [Full-text]
59. Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes.
    Diabet Med, 21(12): 1316-24. [Abstract] [Full-text]
60. Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene and the relationship to beta-cell function during an OGTT in glucose-tolerant women with and without previous gestational diabetes mellitus.
    Diabet Med, 21(12): 1310-5. [Abstract] [Full-text]
61. Early parasympathetic neuropathy associated with elevated fasting plasma C-peptide concentrations and late parasympathetic neuropathy with hyperglycaemia and other microvascular complications.
    Diabet Med, 21(12): 1304-9. [Abstract] [Full-text]
62. Effect of insulin treatment on the body composition of Type 2 diabetic patients.
    Diabet Med, 21(12): 1298-303. [Abstract] [Full-text]
63. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
    Diabet Med, 21(12): 1292-7. [Abstract] [Full-text]
64. Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone.
    Diabet Med, 21(12): 1280-7. [Abstract] [Full-text]
65. Effects of a structured health education programme by a diabetic education nurse on cardiovascular risk factors in Chinese Type 2 diabetic patients: a 1-year prospective randomized study.
    Diabet Med, 21(12): 1274-9. [Abstract] [Full-text]
66. Intravenous drug abuse and Type 1 diabetes: financial and healthcare implications.
    Diabet Med, 21(12): 1269-73. [Abstract] [Full-text]
67. Persistent poor glycaemic control in adult Type 1 diabetes. A closer look at the problem.
    Diabet Med, 21(12): 1263-8. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.